259 related articles for article (PubMed ID: 22555639)
1. The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.
Govender L; Mackraj I; Gathiram P; Moodley J
Cardiovasc J Afr; 2012 Apr; 23(3):153-9. PubMed ID: 22555639
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
3. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
4. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
[TBL] [Abstract][Full Text] [Related]
5. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.
Soto E; Romero R; Kusanovic JP; Ogge G; Hussein Y; Yeo L; Hassan SS; Kim CJ; Chaiworapongsa T
J Matern Fetal Neonatal Med; 2012 May; 25(5):498-507. PubMed ID: 21867402
[TBL] [Abstract][Full Text] [Related]
6. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
Xiang QQ; Yang Z; Huai J; Wang GJ
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
[No Abstract] [Full Text] [Related]
7. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
[TBL] [Abstract][Full Text] [Related]
8. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
9. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
[TBL] [Abstract][Full Text] [Related]
10. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of the anti-angiogenic thrombospondin 2 are elevated in pre-eclampsia.
Stenczer B; Molvarec A; Veresh Z; Gullai N; Nagy GR; Walentin S; Szijártó J; Rigó J
Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1291-5. PubMed ID: 21682699
[TBL] [Abstract][Full Text] [Related]
12. Circulating angiogenic factors in pregnancies complicated by pre-eclampsia.
Varughese B; Bhatla N; Kumar R; Dwivedi SN; Dhingra R
Natl Med J India; 2010; 23(2):77-81. PubMed ID: 20925202
[TBL] [Abstract][Full Text] [Related]
13. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
[TBL] [Abstract][Full Text] [Related]
14. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
[TBL] [Abstract][Full Text] [Related]
16. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M
Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881
[TBL] [Abstract][Full Text] [Related]
17. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
Schaarschmidt W; Rana S; Stepan H
J Perinat Med; 2013 Sep; 41(5):511-6. PubMed ID: 23612628
[TBL] [Abstract][Full Text] [Related]
18. Association between angiogenic factors and signs of arterial aging in women with pre-eclampsia.
Akhter T; Wikström AK; Larsson M; Larsson A; Wikström G; Naessen T
Ultrasound Obstet Gynecol; 2017 Jul; 50(1):93-99. PubMed ID: 27256927
[TBL] [Abstract][Full Text] [Related]
19. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
[TBL] [Abstract][Full Text] [Related]
20. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
